These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7765675)

  • 21. Research exemption/experimental use in the European Union: patents do not block the progress of science.
    Jaenichen HR; Pitz J
    Cold Spring Harb Perspect Med; 2014 Nov; 5(2):a020941. PubMed ID: 25377145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. European opposition to exclusive control over predictive breast cancer testing and the inherent implications for U.S. patent law and public policy: a case study of the Myriad Genetics' BRCA patent controversy.
    Paradise J
    Food Drug Law J; 2004; 59(1):133-54. PubMed ID: 15190928
    [No Abstract]   [Full Text] [Related]  

  • 23. Decoding gene patents in Australia.
    Denley A; Cherry J
    Cold Spring Harb Perspect Med; 2014 Oct; 5(1):a020909. PubMed ID: 25280901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Collaborative research presents special problems for patent seekers.
    Thorne LW; Ergenzinger ER; Spruill WM
    Nat Biotechnol; 2004 Jul; 22(7):901-2. PubMed ID: 15229550
    [No Abstract]   [Full Text] [Related]  

  • 25. [Biotechnology research and generation of patents of interest to the health system].
    Plaza Gómez L; Albert Martínez A
    Med Clin (Barc); 2008 Dec; 131 Suppl 5():55-9. PubMed ID: 19631824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patentable subject matter, TRIPS and the European Biotechnology Directive: Australia and patenting human genes.
    Palombi L
    Univ N S W Law J; 2003; 26(3):782-92. PubMed ID: 16617532
    [No Abstract]   [Full Text] [Related]  

  • 27. [Patents on life? No patent on life!].
    van Raden L
    Dtsch Tierarztl Wochenschr; 1998 Mar; 105(3):90-3. PubMed ID: 9581373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. US to rule on research patent.
    Ruttimann J
    Nature; 2006 Mar; 440(7084):587. PubMed ID: 16572133
    [No Abstract]   [Full Text] [Related]  

  • 29. Patent law and human genome research at the crossroads: the need for Congressional action.
    McKay DL
    Santa Clara Comput High Technol Law J; 1994; 10(2):465-98. PubMed ID: 16514752
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diffuse rules on patent protection of genes. Scientists risk retroactive payment requirements].
    Orn P
    Lakartidningen; 2000 Nov; 97(46):5285-6. PubMed ID: 11116864
    [No Abstract]   [Full Text] [Related]  

  • 31. Patent reform acts ugly.
    Nat Biotechnol; 2007 Nov; 25(11):1187. PubMed ID: 17989652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The need for balancing the regulation of pharmaceutical trademarks between the Food and Drug Administration and the Patent and Trademark Office.
    Boring D; Doninger C
    Food Drug Law J; 1997; 52(1):109-16. PubMed ID: 10346714
    [No Abstract]   [Full Text] [Related]  

  • 33. Ten years of biotech gaffes.
    Hodgson J
    Nat Biotechnol; 2006 Mar; 24(3):270-3. PubMed ID: 16525384
    [No Abstract]   [Full Text] [Related]  

  • 34. Recent US patent legislation: what's new for biotech?
    Gogoris AC; Todaro JC
    Nat Biotechnol; 2000 Feb; 18(2):229-31. PubMed ID: 10657135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genentech stands by original data.
    Henner DJ; Goeddel DV; Heyneker H; Itakura K; Yansura D; Ross M; Miozzari G
    Nature; 1999 May; 399(6734):297-8. PubMed ID: 10360564
    [No Abstract]   [Full Text] [Related]  

  • 36. Patent pools and standard setting in diagnostic genetics.
    Ebersole TJ; Guthrie MC; Goldstein JA
    Nat Biotechnol; 2005 Aug; 23(8):937-8. PubMed ID: 16082359
    [No Abstract]   [Full Text] [Related]  

  • 37. Protecting rights to early-stage technology.
    Shuster MJ; Su H; Blaug S
    Nat Biotechnol; 2003 Jun; 21(6):701-3. PubMed ID: 12776151
    [No Abstract]   [Full Text] [Related]  

  • 38. Patent due diligence in biotechnology transactions.
    Gogoris AC; Clarke PJ
    Nat Biotechnol; 2001 Mar; 19(3):279-81. PubMed ID: 11231565
    [No Abstract]   [Full Text] [Related]  

  • 39. The human use of humanoid beings: chimeras and patent law.
    Rabin S
    Nat Biotechnol; 2006 May; 24(5):517-9. PubMed ID: 16680130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin patent dispute revisits old biotechnology battleground.
    Fox JL
    Nat Biotechnol; 1997 Apr; 15(4):307. PubMed ID: 9094114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.